Long-term efficacy and safety of once-monthly Risperidone ISM® in the treatment of schizophrenia: Results from a 12-month open-label extension study
Sign Up to like & getrecommendations! Published in 2022 at "Schizophrenia Research"
DOI: 10.1016/j.schres.2021.11.030
Abstract: OBJECTIVE To evaluate long-term efficacy, safety and tolerability of Risperidone ISM® in patients with schizophrenia, a multicenter, open-label extension of the PRISMA-3 study was conducted. METHODS Eligible placebo (unstable) and Risperidone ISM® (stabilized) rollover patients… read more here.
Keywords: risperidone ism; safety; study; long term ... See more keywords
Efficacy and safety of once-monthly Risperidone ISM® in schizophrenic patients with an acute exacerbation
Sign Up to like & getrecommendations! Published in 2020 at "NPJ Schizophrenia"
DOI: 10.1038/s41537-020-00127-y
Abstract: To evaluate the efficacy and safety of Risperidone ISM ® against placebo in patients with acute exacerbation of schizophrenia. A multicenter, randomized, double-blind, placebo-controlled study was conducted between June 2017 and December 2018 (NCT03160521). Eligible… read more here.
Keywords: risperidone ism; ism; safety; efficacy ... See more keywords
A phase II study to evaluate the pharmacokinetics, safety, and tolerability of Risperidone ISM multiple intramuscular injections once every 4 weeks in patients with schizophrenia
Sign Up to like & getrecommendations! Published in 2018 at "International Clinical Psychopharmacology"
DOI: 10.1097/yic.0000000000000203
Abstract: This study characterized the pharmacokinetics, safety, and tolerability of Risperidone ISM, a new long-acting intramuscular formulation, for monthly administration without oral supplementation. Patients with schizophrenia received multiple intramuscular injections of 75 mg in the gluteal or… read more here.
Keywords: risperidone ism; study; intramuscular injections; multiple intramuscular ... See more keywords